Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myriad Genetics (MYGN) Goodwill & Intangibles (2016 - 2025)

Myriad Genetics (MYGN) has disclosed Goodwill & Intangibles for 15 consecutive years, with $163.1 million as the latest value for Q3 2025.

  • On a quarterly basis, Goodwill & Intangibles fell 47.81% to $163.1 million in Q3 2025 year-over-year; TTM through Sep 2025 was $163.1 million, a 47.81% decrease, with the full-year FY2024 number at $548.7 million, down 13.85% from a year prior.
  • Goodwill & Intangibles was $163.1 million for Q3 2025 at Myriad Genetics, down from $548.7 million in the prior quarter.
  • In the past five years, Goodwill & Intangibles ranged from a high of $666.5 million in Q4 2022 to a low of $163.1 million in Q3 2025.
  • A 5-year average of $525.5 million and a median of $620.1 million in 2022 define the central range for Goodwill & Intangibles.
  • Peak YoY movement for Goodwill & Intangibles: skyrocketed 71.17% in 2021, then plummeted 47.81% in 2025.
  • Myriad Genetics' Goodwill & Intangibles stood at $643.3 million in 2021, then rose by 3.61% to $666.5 million in 2022, then fell by 4.44% to $636.9 million in 2023, then fell by 13.85% to $548.7 million in 2024, then crashed by 70.28% to $163.1 million in 2025.
  • Per Business Quant, the three most recent readings for MYGN's Goodwill & Intangibles are $163.1 million (Q3 2025), $548.7 million (Q4 2024), and $312.5 million (Q3 2024).